Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2005 5
2006 2
2007 3
2008 5
2009 6
2010 11
2011 6
2012 11
2013 13
2014 12
2015 10
2016 14
2017 16
2018 14
2019 23
2020 13
2021 16
2022 20
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Paton NI, Cousins C, Suresh C, Burhan E, Chew KL, Dalay VB, Lu Q, Kusmiati T, Balanag VM, Lee SL, Ruslami R, Pokharkar Y, Djaharuddin I, Sugiri JJR, Veto RS, Sekaggya-Wiltshire C, Avihingsanon A, Sarin R, Papineni P, Nunn AJ, Crook AM; TRUNCATE-TB Trial Team. Paton NI, et al. Among authors: nunn aj. N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20. N Engl J Med. 2023. PMID: 36808186 Clinical Trial.
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, Bentley A, Kahan BC, Wrightson JM, Davies HE, Hooper CE, Lee YC, Hedley EL, Crosthwaite N, Choo L, Helm EJ, Gleeson FV, Nunn AJ, Davies RJ. Rahman NM, et al. Among authors: nunn aj. N Engl J Med. 2011 Aug 11;365(6):518-26. doi: 10.1056/NEJMoa1012740. N Engl J Med. 2011. PMID: 21830966 Free article. Clinical Trial.
Multidrug-resistant tuberculosis.
Nyang'wa BT, Berry C, Fielding K, Nunn AJ. Nyang'wa BT, et al. Among authors: nunn aj. Lancet. 2019 Jul 27;394(10195):298-299. doi: 10.1016/S0140-6736(19)30691-9. Lancet. 2019. PMID: 31354136 No abstract available.
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Narendran G, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: nunn aj. Lancet. 2022 Nov 26;400(10366):1858-1868. doi: 10.1016/S0140-6736(22)02078-5. Epub 2022 Nov 8. Lancet. 2022. PMID: 36368336 Free PMC article. Clinical Trial.
Treatment of pulmonary tuberculosis.
Nunn A, Phillips PP, Abubakar I. Nunn A, et al. Curr Opin Pulm Med. 2013 May;19(3):273-9. doi: 10.1097/MCP.0b013e32835f27f8. Curr Opin Pulm Med. 2013. PMID: 23528955 Review.
Linezolid for drug-susceptible tuberculosis.
Ahmed S, Moore DA, Nimmo C, Nunn AJ, Yates TA; North London TB Journal Club. Ahmed S, et al. Among authors: nunn aj. Lancet Infect Dis. 2019 Apr;19(4):357. doi: 10.1016/S1473-3099(19)30110-0. Epub 2019 Mar 27. Lancet Infect Dis. 2019. PMID: 30938294 No abstract available.
Advances in clinical trial design: Weaving tomorrow's TB treatments.
Lienhardt C, Nunn A, Chaisson R, Vernon AA, Zignol M, Nahid P, Delaporte E, Kasaeva T. Lienhardt C, et al. Among authors: nunn a. PLoS Med. 2020 Feb 27;17(2):e1003059. doi: 10.1371/journal.pmed.1003059. eCollection 2020 Feb. PLoS Med. 2020. PMID: 32106220 Free PMC article. Review.
216 results